View-only open access link: rdcu.be/dUWzz
www.annalsofoncology.org/article/S092...
A balanced critique of our recent biomarker analysis within the FOLFOX+/-panitumumab FOxTROT1 substudy.
Is there a new role for anti-EGFR agents in locally advanced colon cancer?
www.annalsofoncology.org/article/S092...
A balanced critique of our recent biomarker analysis within the FOLFOX+/-panitumumab FOxTROT1 substudy.
Is there a new role for anti-EGFR agents in locally advanced colon cancer?
Stunning Yorkshire day for it! ☀️
Stunning Yorkshire day for it! ☀️
Check out our latest #AnnalsOfOncology paper:
www.annalsofoncology.org/article/S092...
@jenseligmann.bsky.social
Check out our latest #AnnalsOfOncology paper:
www.annalsofoncology.org/article/S092...
@jenseligmann.bsky.social
An amazing story! And hopefully many more stories like this to come following TRANSMET
www.thelancet.com/journals/lan...
An amazing story! And hopefully many more stories like this to come following TRANSMET
www.thelancet.com/journals/lan...
View-only open access link: rdcu.be/dUWzz
View-only open access link: rdcu.be/dUWzz
@wearelcrc.bsky.social
www.instagram.com/reel/DCYuFfz...
@wearelcrc.bsky.social
www.instagram.com/reel/DCYuFfz...